Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Karyopharm Therapeutics (KPTI) Amortization of Deferred Charges (2019 - 2025)

Karyopharm Therapeutics' Amortization of Deferred Charges history spans 9 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 3.73% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $10.5 million, up 65.58%, while the annual FY2025 figure was $10.5 million, 65.58% up from the prior year.
  • Amortization of Deferred Charges reached $2.4 million in Q4 2025 per KPTI's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.8 million in Q3 2025 to a low of $191000.0 in Q1 2021.
  • Average Amortization of Deferred Charges over 5 years is $966050.0, with a median of $206500.0 recorded in 2023.
  • Peak YoY movement for Amortization of Deferred Charges: plummeted 90.64% in 2021, then soared 1137.02% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $199000.0 in 2021, then grew by 5.53% to $210000.0 in 2022, then grew by 3.33% to $217000.0 in 2023, then skyrocketed by 986.18% to $2.4 million in 2024, then rose by 3.73% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for KPTI's Amortization of Deferred Charges are $2.4 million (Q4 2025), $2.8 million (Q3 2025), and $2.7 million (Q2 2025).